Novo Nordisk NVO has experienced remarkable growth in recent years, largely fueled by the commercial success of its ...

Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...

Pedersen, Global Head of Pharma Technical Operations at Roche, shares how she has navigated the various pivots in her career, ...

Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...